Journal of Cellular Signaling
ISSN: 2692-0638

Review Article - Journal of Cellular Signaling (2021) Volume 2, Issue 4

Ethanol Consumption and Sepsis: Mechanisms of Organ Damage

Alessandra Oliveira Silva1, Clare C. Prohaska2, Carla Speroni Ceron3*

1Departamento de Alimentos e Medicamentos, Universidade Federal de Alfenas (UNIFAL-MG), Minas Gerais, Brasil

2Division of Pulmonary, Critical Care, Occupational and Sleep Medicine, Indiana University, Indianapolis, IN, USA

3Departamento de Ciências Biológicas, Universidade Federal de Ouro Preto (UFOP), Minas Gerais, Brasil

*Corresponding Author:
Carla Speroni Ceron
E-mail:carla.ceron@ufop.edu.br

Received date: June 30, 2021; Accepted date: September 29, 2021

Citation: Silva AO, Prohaska CC, Ceron CS. Ethanol Consumption and Sepsis: Mechanisms of Organ Damage. J Cell Signal 2021; 2(4): 235-241.

Copyright: © 2021 Silva AO, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Abstract

Sepsis is highly prevalent, and is one of the main causes of mortality among hospitalized patients. Ethanol consumption in large quantities compromises the normal functioning of the body, leading to dysfunction of multiple different organ systems. The association between sepsis and ethanol is not fully understood, but it is well accepted that ethanol consumption plays a role in the development of sepsis. Both sepsis and ethanol cause inflammatory dysfunction and promote oxidative stress. Antioxidant agents may be highly relevant targets to abrogate the effects of sepsis in patients who also consume large amounts of ethanol. This review focuses on presenting the main mechanisms involved between sepsis and ethanol consumption, and to describe the main antioxidants that have been used as therapeutic agents.


Keywords

Ethanol consumption, Sepsis, Oxidative stress, Antioxidant defense, Inflammation, Antioxidant agents, Sepsis mortality


Introduction

Sepsis is considered one of the main causes of death in the world, and can be aggravated by acute or chronic exposure to ethanol [1], directly affecting vascular function [2]. According to the World Health Organization (WHO), 43% of the world population consumes ethanol [3]. Chronic ethanol consumption increases risk for the development of sepsis , sepsis mortality and costs of patient hospitalization [1,4].

Increased mortality in sepsis after ethanol consumption has also been observed in animal models of induced sepsis. Alterations in permeability in the hepatic, vascular, pulmonary, renal, and gastrointestinal systems are caused primarily by ethanol consumption [2,5,6]. The main pathogenic mechanisms implicated in both sepsis and ethanol consumption involve the activation of the immune system, releasing anti-inflammatory and pro-inflammatory mediators, as well as the activation of the antioxidant system [1,5,7,8], which has been demonstrated in both animal and human studies [2,5,9,10]. Experimental studies have suggested that antioxidant agents may be used to try to reverse these pathologic mechanisms [9-12].

The focus of this review is to address the main mechanisms between increased sepsis mortality associated with ethanol consumption, giving an overview of the inflammatory processes involved. In particular, we will focus on the oxidative processes that occur as well as the possible benefits of using antioxidant compounds to prevent organ dysfunction in the setting of sepsis and ethanol consumption.

We performed an active literature search using the terms "ethanol and sepsis", "ethanol, sepsis and pathologies", "ethanol and organ disorders", “sepsis and organ disorders”, “epidemiology of ethanol”, “sepsis and ethanol and antioxidants”, “sepsis and ethanol and oxidative stress” using Medline, Scopus, Web of Science, ScienceDirect, PLoS databases, between 2001 to 2021. Only articles published in English language were included. Analysis of the information started with the title, abstract and then the full report.


Sepsis and Ethanol Consumption Epidemiology

Alcohol use disorders are considered a serious public health problem [13,14]. According to the most recent data from the WHO, it is estimated that in the last year about 43% of the global population consumed alcohol, with an average of 6.4 liters of pure alcohol per capita. In Brazil, it is estimated that 40% of the population consumed alcohol in the last 12 months, with the estimated consumption per person in 2016 7.8 liters of pure alcohol, higher than the world average. In addition, Brazilian men have a higher prevalence in the consumption of alcohol when compared to women [3].

Excessive alcohol consumption may lead to chronic organ dysfunction, particularly in the gastrointestinal tract, liver and pancreas. It is a potent modulator of the immune system that can lead to chronic dysregulation [4]. Ethanol can modulate the antioxidant system, leading to increased production of reactive oxygen species (ROS) [2]. The extent of the effects caused by ethanol is influenced by factors such as consumption pattern, quantity ingested, gender and organ system affected [15].

Chronic consumption of ethanol is directly related to susceptibility to infections due to direct toxic effects on the immune system [4,16,17]. Bacterial infections are the main complication in patients with liver disease related to alcoholism in a hospital environment [18]. According to one study, between 20 to 40% of hospitalized patients have at least one condition associated with chronic ethanol consumption [19].

Studies have shown that rats that chronically consumed ethanol and later developed sepsis had a higher mortality rate compared to control animals. Furthermore, the mortality rate is directly related to the amount of alcohol consumed, with higher consumption associated with increased mortality [4,6,19]. If mice that were subjected to sepsis were given ethanol, their overall survival was decreased at 72 hours [20]. Mice that chronically consume alcohol have fewer infections during periods of abstinence, with fewer mice developing sepsis during abstinent periods [17].

Alcohol consumption is associated with impaired immune responses patients requiring intensive care unit (ICU) level of care, with increased ICU length of stay and a high risk of death [13,14]. In addition, alcoholic patients are more likely to develop sepsis [13,14], with higher hospital mortality and increased hospitalization days [4,21]. According to the latest data from the WHO, 12.9% of deaths from infectious diseases were attributed to the ethanol consumption [3].

Sepsis is considered an inflammatory response in response to infection that causes cell damage in many tissues. This condition is highly prevalent, especially in the population over 85 years old, in addition to being one of the main causes of morbidity and mortality in the intensive care unit worldwide [1,4,5,22]. This pathology can be divided into 4 categories: systemic inflammatory response syndrome, which does not yet verify an infectious process itself; sepsis, where the installation of the infectious process has already been confirmed [22]; severe sepsis, which is mainly associated with multiple organ failure [5,22]; and septic shock, characterized by low blood pressure and organ failure with a more imminent risk of death [22].

During sepsis, an increase in the levels of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) [4,15], and decrease in CD4+ and CD8+ lymphocytes [6] was observed. There is an induction of intestinal epithelial apoptosis, which favors an increase in the permeability of the intestine, thus causing an increase in the systemic inflammatory process, since the intestine is closely linked to the immune system [6].

The association of ethanol consumption with sepsis and the mechanisms involved between increased mortality seen in alcoholic patients to sepsis is still quite controversial. It seems to be associated with the attenuation of the innate and acquired immune response and, consequently, a decrease in the bactericidal activity of macrophages and neutrophils [1,4]. Furthermore, these patients may have chronic malnutrition, leading to [1,4] and marked apoptosis, particularly in intestinal cells [6].


Mechanisms Mediated by the Immune System in Ethanol Consumption and Sepsis

The human immune system has two mechanisms to protect itself, innate and adaptive immunity. Macrophages are the primary cell associated with innate immunity associated with damage caused by sepsis [7,23]. Macrophages ingest microbes as well as release pro-inflammatory cytokines, classically TNF-α and IL-6 [7,23,24]. Additionally, sepsis promotes a marked decrease in CD4+ and CD8+ lymphocytes, and ethanol consumption further reduces this process [6]. CD4+ lymphocytes are responsible for robust inflammation and activation of host defenses with production of TNF-α and interferon-gamma (IFN-γ) [25].

Sepsis may increase the levels of IL-6 and TNF-α [4,15], damaging different organs [5,26] culminating in septic shock [22]. Increased levels of blood urea nitrogen and creatinine may occur during sepsis, important markers of kidney damage [4]. Ethanol may also contribute to high creatinine and urea levels [15], leading to kidney damage and acute tubular necrosis [5]. Up to 50% of patients develop acute kidney injury in sepsis [1,5].

Sepsis among patients with alcohol abuse is also associated with worsening of intestinal cell apoptosis, increased gut permeability and reduced villous length, all of which are linked to increased mortality [27]. It is believed that there is greater translocation of bacteria and bacterial products through the intestinal lumen. In studies of animals subjected to sepsis by cecal ligation and puncture that maintain the intestinal barrier, there is better prognosis [6].

The ways in which ethanol can aggravate sepsis are not fully elucidated. Ethanol consumption directly affects immune function, leading to a decrease in the lymphocytic response, as well as alteration in cytokine production by lymphocytes and macrophages [15]. Other studies have demonstrated that the administration of ethanol suppresses the elimination of bacteria present in sepsis, with decreased pro-inflammatory chemokine levels (TNF-α and IL-6) [1,4,26]. The decrease in TNF-α itself may be responsible for the decreased recruitment of neutrophils, resulting in a less robust immune response [4].

The association of ethanol with sepsis increases the levels of TNF-α and IL-6 in plasma [2] and renal tissue [5]. Yoseph et al. observed that mice subjected to sepsis and exposed to ethanol for 12 weeks demonstrated an upregulation in the production of TNF-α and IFN-γ in CD4+ cells [6]. However, theoretical differences may be temporally associated with the sepsis, since the initial phase of sepsis is characterized by hyperinflammation and in the late phase, hypoinflammation is observed, characterized by a decrease in pro-inflammatory mediators. These divergences may also be related to the ethanol concentrations used or gender [8,15].


Mechanisms Mediated by Oxidative Stress in Ethanol Consumption and Sepsis

Oxidative stress is defined by the disequilibrium between oxidizing compounds and the antioxidant system, culminating in cellular and tissue oxidative damage. The main ROS important in sepsis and ethanol consumption are the superoxide anions (O2•-), the hydroxyl radical (OH), and the hydrogen peroxide (H2O2). Furthermore, O2•- can react with NO (nitric oxide) to form peroxynitrite (ONOO-), an important marker of lipid peroxidation, detected through the presence of malonaldehyde [28,29].

Antioxidant enzymes are responsible for inhibiting or reducing the damage caused by oxidizing agents, particularly superoxide dismutase (SOD), Catalase and Glutathione Peroxidase (GPx). SOD converts O2•- into H2O2 and molecular oxygen. Catalase and GPx prevent the formation of H2O2 [28-30]. In addition, GPx is important for the balance of the glutathione redox cycle, controlling reduced and oxidized glutathione [28,29]. Therefore, changes in oxidized glutathione levels are an indicator of increased oxidative stress [31].

The increase in reactive oxygen species and lipoperoxidation leads to the activation of metalloproteinase (MMPs), especially MMP-2 and MMP-9, which are closely linked with the development of tissue pathology, as they promote the remodeling and degradation of the extracellular matrix [5,11]. MMP-2 is usually of mesenchymal origin, while MMP-9 is derived from macrophages during inflammatory processes [32].

Ethanol consumption promotes a modulation of the antioxidant system through the activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and increased expression of inducible nitric oxide synthase. This mechanism causes an increase in reactive oxygen species, with greater lipid lipoperoxidation as well as vascular dysfunction [2,5]. Studies have indicated an increase in malonaldehyde levels in different organs, confirming this pathway [12,33].

Ethanol consumption can modulate oxidizing enzymes in different ways, depending on the organ being studied. Some studies show a decrease in GSH levels in the vascular tissue of animals and an increase in catalase activity [2]. In the renal system, increases in MMPs, ROS and pro-inflammatory cytokines [5,34] suggest a poor prognosis in individuals with sepsis, since half of those affected by sepsis develop acute kidney injury [5]. Decreased catalase and SOD activity have been noted in the liver [33].

There is a strong interaction between inflammatory processes and the formation of reactive oxygen species, favoring redox imbalance in sepsis [11]. Animals submitted to sepsis showed increases in MMP-2 [11] and MMP-9 [32,35], with decreased SOD and catalase activity [30]. In addition, MMP-9 can be used as a marker of sepsis severity [32]. Furthermore, macrophages present in inflammation resulting from sepsis act by producing ROS (O2•-, OH, H2O2) and NO during the phagocytosis process. NO, which is absent in resting macrophages, is activated by the presence of INF-γ, which is also an important proinflammatory mediator [7,30] and favors the production of inflammatory cytokines such as IL- 6 and TNF-α [23].

Chronic ethanol consumption increases the risk of acute lung injury by depleting glutathione. Resulting tissue alterations, such as decreased surfactant processing, decreased barrier integrity, and increased apoptosis are associated with an increase in the susceptibility to sepsis [36].

Oxidative stress induced by ethanol chronic consumption plays a role in several aspects of alcohol-related liver disease. Ethanol metabolism produces excessive acetaldehyde, reactive oxygen species and protein and DNA adducts. These alterations lead to the expression of pro-inflammatory mediators in the liver, structural and functional dysregulation of mitochondria, causing hepatocyte apoptosis and necrosis [37]. Sepsis increased lipidic peroxidation and oxidative stress in the liver of rats submitted to acute ethanol consumption. These early changes in oxidative stress caused in the liver by ethanol were associated with increased sepsis-related organ damage [38]. In addition, chronic and acute ethanol consumption are associated with enhanced cardiac oxidative and nitrative stress, damage in mitochondrial function, cardiomyocyte hypertrophy and cardiac steatosis [16,39].

Figure 1 summarizes the of mechanisms of tissue damage in chronic ethanol consumption and sepsis, focused in the immune system alterations and oxidative stress.


Antioxidants as an Alternative Treatment in Ethanol Consumption and Sepsis

Antioxidant agents are defined as substances that, in the presence of an oxidizing compound, effectively delay or inhibit oxidation. Most of these compounds have both antioxidant and anti-inflammatory properties [28,29]. Currently, different studies aim to evaluate the use of antioxidant substances for the treatment of chronic consumption of ethanol and sepsis.

Ethanol consumption increased O2•- and increased IL-10 levels in the mesenteric arterial bed of chronic ethanol treated rats. Ethanol also increased plasma levels of TBARS, TNF-α, IL-6, IL-1β, and IL-10. Apocynin, an antioxidant inhibitor of the enzyme NADPH oxidase, prevented these alterations and reduced endothelial dysfunction induced by ethanol in resistance arteries [24]. In another experimental study, ethanol chronic consumption increased O2 generation and lipid peroxidation in the aorta of rats and apocynin prevented these responses [40].

The antioxidant ascorbic acid or vitamin C prevented endothelial dysfunction in the aorta of rats with acute ethanol intake. However, vitamin C was not able to revert the increased O2•- generation in the aorta of ethanol treated mice. However,an increase in SOD activity was observed with the use of the antioxidant [41].

Rats submitted to chronical ethanol consumption were treated with melatonin, a hormone with indirect antioxidant activities by increasing antioxidant enzymes activities, and vitamin C. Ethanol increased aortic and plasma lipidic peroxidation and treatment with melatonin and vitamin C reduced these alterations, but not the alterations in SOD and catalase activities caused by ethanol [42]. In another study, the antioxidant effect of melatonin and vitamin C was evaluated by renal injury induced by chronic alcohol consumption in rats. In this study, ethanol increased the formation of lipid peroxides, SOD and catalase activities in the kidney, while melatonin treatment reduced only the lipidic peroxidation in the kidneys [43].

Hepatic mitochondria are injured by both acute and chronic ethanol consumption. Manganese superoxide dismutase (MnSOD) overexpression in mice prevented liver mitochondrial DNA depletion, ROS formation, decreased mitochondrial glutathione and increased inducible nitric oxide synthase (NOS) expression induced by acute ethanol exposure. However, when mice were subjected to chronic ethanol consumption, the mitochondrial damage was worsened by the overexpression of this antioxidant enzyme [44].

Regarding sepsis, treatment with antioxidants seems to have interesting results. Mice subjected to cecal ligation and puncture (CLP) model of sepsis treated with the antioxidant curcumin presented less inflammatory damage in the lung and kidney. This response was associated with increased plasmatic IL-10 levels and inhibition of the secretion of plasma TNF-α and IL-6 septic mice after the treatment with the antioxidant [9]. Furthermore, the administration of blackberry extracts in a mouse model of sepsis induced by LPS decreased leukocytes in bronchoalveolar lavage, decreased TNF levels in the serum and decreased GPx and MMP-2 activity of septic animals. These results were associated to an improvement in the survival rate in sepsis [11].

Treatment of septic models with melatonin reduced the lipidic peroxidation in the liver, brain, lung and kidneys and attenuated pulmonary inflammation of LPS-induced and CLP-induced septic models. The attenuation of the cytokine response observed with the treatment improved the survival rate of septic models [45].

Vitamin C is emerging as a potential treatment to sepsis. The administration of high intravenous dose of vitamin C attenuated oxidative stress, inflammation, improved the synthesis of vasopressor and enhanced immune cell function in septic patients [46]. Several recent clinical trials intend to prove the benefits and the safety of vitamin C in the treatment of sepsis, including potential improvements in mortality rates [47-49].

Fewer studies investigate the role of antioxidants in the treatment of chronic ethanol consumption associated with increased sepsis susceptibility and mortality. Decreased melatonin levels in alcoholic individuals have been associated with increased intestinal permeability endotoxemia in patients with alcohol abuse [50]. Pretreatment of mice with melatonin stabilized erythrocyte membranes and decreased oxidative stress [51]. In order to further investigate the effect of antioxidants in ethanol consumption and sepsis, a clinical trial was recently registered to investigate the effect of Vitamin C Infusion for treatment in Sepsis and Alcoholic Hepatitis (CITRIS-AH) and started in 2019 which will be completed in 2022 (ClinicalTrials.gov Identifier: NCT03829683) [52]. The use of antioxidants as an alternative treatment in the increased susceptibility to sepsis induced by ethanol consumption remains a poorly explored theme in the literature and requires further research.


Conclusions

Sepsis is a public health problem that requires new, more effective therapies. Ethanol consumption increases sepsis mortality by mechanisms that have not been fully elucidated. The imbalance of the antioxidant system could be a potential target for the treatment of sepsis and ethanol consumption. However, studies demonstrating the effect of antioxidants on the association of ethanol with sepsis are scarce in the literature. Therefore, further studies, both experimental and clinical, to analyze the effect of antioxidants on organ damage and increased susceptibility to sepsis observed in ethanol consumption are needed.


Conflicts of interest

There is no conflict of interest.


Acknowledgements

This study was supported by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Capes), Conselho Regional de Desenvolvimento Científico e Tecnológico (CNPq) and Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG). Figure was created with BioRender.com.


Author Contributions

Silva A.O., Conceptualization and Original draft preparation.

Prohaska C.C., Reviewing and editing.

Ceron C.S., Conceptualization, Original draft preparation, Reviewing and editing.


References